Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117882384 | 11788238 | 4 | F | 20141203 | 20160831 | 20151201 | 20160906 | EXP | CA-ROCHE-1669822 | ROCHE | 45.51 | YR | F | Y | 0.00000 | 20160906 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117882384 | 11788238 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 117882384 | 11788238 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 117882384 | 11788238 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 117882384 | 11788238 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 117882384 | 11788238 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 117882384 | 11788238 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 117882384 | 11788238 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 117882384 | 11788238 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 117882384 | 11788238 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0062,S0001E,S00002F | 103976 | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117882384 | 11788238 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117882384 | 11788238 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117882384 | 11788238 | Amnesia | |
| 117882384 | 11788238 | Aphasia | |
| 117882384 | 11788238 | Blood pressure diastolic increased | |
| 117882384 | 11788238 | Body temperature decreased | |
| 117882384 | 11788238 | Concussion | |
| 117882384 | 11788238 | Contusion | |
| 117882384 | 11788238 | Ear infection | |
| 117882384 | 11788238 | Heart rate increased | |
| 117882384 | 11788238 | Lung infection | |
| 117882384 | 11788238 | Nasopharyngitis | |
| 117882384 | 11788238 | Respiratory disorder | |
| 117882384 | 11788238 | Road traffic accident | |
| 117882384 | 11788238 | Sinusitis | |
| 117882384 | 11788238 | Weight decreased | |
| 117882384 | 11788238 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117882384 | 11788238 | 1 | 20141119 | 0 | ||
| 117882384 | 11788238 | 2 | 20141216 | 0 | ||
| 117882384 | 11788238 | 3 | 20150317 | 0 | ||
| 117882384 | 11788238 | 4 | 20150331 | 0 | ||
| 117882384 | 11788238 | 5 | 20150915 | 0 | ||
| 117882384 | 11788238 | 6 | 20160329 | 0 | ||
| 117882384 | 11788238 | 7 | 20160607 | 0 | ||
| 117882384 | 11788238 | 8 | 20160816 | 0 | ||
| 117882384 | 11788238 | 9 | 20160831 | 0 |